Wholesale/Supplier Pharmaceutical Intermediate Mildronate CAS 76144-81-5

Min.Order: 1
Product origin: Xi'an, Shaanxi, China
Infringement complaint: complaintComplaint
US$ 90 ~ 120

Description


Wholesale Pharmaceutical Intermediate  Mildronate CAS 76144-81-5

Product Name
 Wholesale Pharmaceutical Intermediate  Mildronate CAS 76144-81-5
MF
C6H14N2O2
Appearance
White crystalline powder
Assay
99% min
Storage
Keep in a cool, dry, dark location
Shelf Life
24 Months

What is Mildronate ?
Mildronate is a structural analog of carnitine that competes in the inhibition of butyrate betaine hydroxylase, thereby inhibiting the biosynthesis of carnitine, which directly inhibits the transport of carnitine-dependent fatty acids in mitochondria. Inhibition of carnitine biosynthesis can reduce the concentration of intracellular free carnitine and prevent isoproterenol-induced acyl carnitine accumulation. Therefore, the drug has a significant protective effect on the myocardium, resulting in this protective effect at the same time on the hemodynamic parameters had no significant effect, cardiac blood supply and cardiac oxygen consumption was no significant change


 
 
Function of Mildronate:

1. Mildronate powder is a novel cardioprotective agent.

2.Mildronate acts on mitochondria at the cellular level to improve myocardial energy
metabolism. In view of these drugs and other anti-myocardial ischemia significantly different,
also known as cell anti-ischemic drugs.

3. Mildronate is a structural analog of carnitine that competes in the inhibition of butyrate
betaine hydroxylase, thereby inhibiting the biosynthesis of carnitine, which directly inhibits
the transport of carnitine-dependent fatty acids in mitochondria. Inhibition of carnitine
biosynthesis can reduce the concentration of intracellular free carnitine and prevent
isoproterenol-induced acyl carnitine accumulation.

Therefore, the drug has a significant protective effect on the myocardium, resulting in this
protective effect at the same time on the hemodynamic parameters had no significant
effect, cardiac blood supply and cardiac oxygen consumption was no significant change







Product Tag:
Related categories:
Scroll to Top